IMC Chicago
LABU icon

IMC Chicago’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

IMC Chicago’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,558
Closed -$259K – 6583
2026
Q1 		$259K Sell
1,558
-13,087
-89% -$2.15M ﹤0.01% 4754
2025
Q4 		$2.33M Sell
14,645
-26,015
-64% -$3.57M ﹤0.01% 2289
2025
Q3 		$3.81M Buy
+40,660
New +$2.87M ﹤0.01% 1766
2023
Q4 		– Sell
-11,206
Closed -$854K – 1882
2023
Q3 		$854K Buy
11,206
+1,309
+13% +$134K ﹤0.01% 1277
2023
Q2 		$1.17M Sell
9,897
-333
-3% -$41.5K ﹤0.01% 1019
2023
Q1 		$1M Sell
10,230
-2,899
-22% -$393K ﹤0.01% 1032
2022
Q4 		$1.86M Buy
13,129
+8,253
+169% +$1.15M ﹤0.01% 831
2022
Q3 		$684K Buy
+4,876
New +$894K ﹤0.01% 1033
2019
Q3 		– Sell
-1,421
Closed -$1.43M – 770
2019
Q2 		$1.43M Sell
1,421
-885
-38% -$857K ﹤0.01% 482
2019
Q1 		$2.76M Buy
+2,306
New +$2.4M 0.01% 322

Other funds holding LABU

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.5B AUM 22.75% 1-Year Est. Return

IMC Chicago's LABU Position: Q2 2026 in Review

IMC Chicago sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2026, closing a stake of 1,558 shares — an estimated $259K sold.

IMC Chicago first reported a position in LABU in Q1 2019 and held it in 10 quarters. The position peaked at $3.81M in Q3 2025. 36 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

  • IMC Chicago reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q2 2026 after selling out during the quarter.
  • IMC Chicago sold 1,558 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2026, an estimated $259K.
  • IMC Chicago first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2019 and held it in 10 quarters.
  • IMC Chicago's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $3.81M in Q3 2025.
  • 36 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.